Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

chiltern logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:
Research & Development: Clinical (Phase 1, Phase 2, Phase 3)


Main Service Areas:
Clinical


Services & Capabilities:
Chiltern is a fullservice global contract research organization offering services in: early phase, global clinical development, late phase, biometrics, medical & regulatory affairs, functional service provision, and contract staffing.

Therapeutic Areas:
CNS, infectious diseases & vaccines, oncology, ophthalmology, pediatrics, cardiorespiratory.

Jim Esinhart

CEO

“Chiltern is honored to be recognized three years running by distinguished members of the biopharmaceutical industry as a CRO leader in quality, reliability, innovation, productivity, and regulatory. Chiltern prides itself as a global, midtier development partner that offers flexibility, responsiveness, and quality delivery. On behalf of our Chiltern colleagues working around the world, it is a pleasure to accept this award.”